Top 10 Oil and Gas Startup Investors in Switzerland in January 2025
A list of 10 angel investors and VC (Venture Capital) funds that invest in Oil and gas startups based in Switzerland. We rank investors based on the number of investments they made in Oil and gas companies from Switzerland. We update this investor list every month.Top 10 Oil and Gas Startup Investors in Switzerland in January 2025
Investor | Oil and Gas Switzerland investments |
---|---|
Singular | 3 |
Agility | 2 |
Founderful | 2 |
VINCI CAPITAL | 1 |
FirstMark | 1 |
Foundation for Innovation and Technology (FIT) | 1 |
Amadeus APEX Technology Fund | 1 |
Qemetica Ventures (Formerly Ciech Ventures) | 1 |
SICTIC | 1 |
Zürcher Kantonal Bank | 1 |
Singular is a generalist venture capital firm backing ambitious European entrepreneurs.
Show more
Investment focus
- Software, Analytics, Machine Learning
- Series A, Seed, Series B
- France, Germany, Belgium
Portfolio highlights
- Prelude — Prelude is advancing SMS verification and mobile onboarding infrastructure through a set of unified APIs developers might actually like. Prelude is dedicated to more reliable fraud detection, elegant transparency, and increased reliability– all at a better price, so businesses can make every ping count for their customer experience, not their bill.
- Orakl Oncology — Cultivated with love by the Orakl team.
- Basecamp Research — Novel proteins from nature. We sample the most extreme and exciting places on the planet to build the world's largest knowledge graph of natural biodiversity.
Agility operates and invests in companies that transform supply chains by making them smarter, faster, cleaner, fairer and more efficient. Click to learn more.
Show more
Investment focus
- Apps, Solar, Travel
- Series A, Series B, Series C
- Egypt, Sweden, Switzerland
Portfolio highlights
- Swvl — Swvl | Book Your Daily Ride or Make Money Driving Now
- TVP Solar — TVP Solar SA is a Swiss company which designs, develops, manufactures and markets innovative, high-vacuum flat solar thermal panels based on a proprietary technology for cooling and heating applications.
- Volta Trucks — Electric trucks for sustainable cities, with people at the heart of everything we do.
Founderful operates as a venture capital firm and a Switzerland’s leading pre-seed fund.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Pre-Seed, Seed, Series A
- Switzerland, United Kingdom, Canada
Portfolio highlights
- Sallea — Sallea is dedicated to pioneering a sustainable future in meat and fish consumption by developing innovative structures for cellular agriculture. This approach allows cells to grow into textured and flavorful whole cuts, ensuring that the products are not only cruelty-free but also safe for consumers. By focusing on these unique methods, Salleaaims to transform the way we think about protein sources, making them more environmentally friendly and ethically produced.
- Apheros — Apheros is a metal foam cooling solutions company. It offers a patent-pending, easily scalable manufacturing approach for metal foams with unique cooling qualities.
- Kyan Health — Prioritise your employees' mental health and well-being with Kyan Health. Our evidence-based solutions address employees' mental well-being, stress at work & boost your workforce productivity.
Vinci Capital is a leading Swiss private equity firm with over MCHF 200 under management. Since 1998 they have provided equity to over 30 Swiss technology and industrial companies to finance innovation, growth and succession-buyouts.Their investment team capitalizes on 40 years of cumulated experience in private equity and a solid operationalbackground in growth, turn-around, consolidation, IPOs and M&A situations.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Series A, Series B, Funding Round
- Switzerland, Germany
Portfolio highlights
- Anergis — Anergis, a clinical-stage biopharmaceutical company, discovers and develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization. It offers vaccines against birch pollen, ragweed pollen, and house dust mite allergies. Francois Spertini founded Anergis in 2001. Its headquarters in Lausanne inSwitzerland.
- SENSIMED — Sensimed designs, develops, and commercializes integrated micro-systems for medical devices. The company’s product portfolio includes SENSIMED Triggerfish, a product that offers an automated recoding of continuous ocular dimensional change over 24 hours. Sensimed is now focused on expanding the knowledge of how this individual data can best beused in the clinical setting to deliver customized treatment. The 24 hour profiles are being centralized on a registry together with patient and treatment information. The data is being analyzed and modeled on an ongoing basis in an attempt to identifying pathological patterns that can be used to differentiate indication, personalize treatment and assess efficacy following treatment.Sensimed was founded by Matteo Leonardi and Sacha Cerboni in August 2003 and is based in Lausanne, Switzerland.
- Beqom — beqom is a Total Compensation Management Software Solution focused exclusively on managing compensation & performance for HR & Sales.
FirstMark is an early-stage venture capital firm in New York City. We back and accelerate founders making their mark on the world.
Show more
Investment focus
- Software, SaaS, E-Commerce
- Series A, Series B, Seed
- United States, United Kingdom, Canada
Portfolio highlights
- Roon — Your Trusted Guide for Health Conditions. Today we are focused on GBM, ALS, Dementia, and Fertility and Family Building.
- Dynamo — Dynamo is a media platform focusing on business journalism.
- Aspect Build — Discover Aspect Build's innovative platform for monorepos, designed to streamline your development workflows, accelerate build times, and boost project efficiency.
The Foundation for Technology Innovation gives financial assistance to creative and technological projects at various phases of development. FIT funds projects in energy and the environment, information and digital technology, life sciences and health, precision industries, and nutrition and agriculture.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Debt Financing, Grant, Seed
- Switzerland, France
Portfolio highlights
- Aspivix — ASPIVIX is developing a new generation of medical devices that make gynecological procedures gentler and safer for women and gynecologists. The first device, CAREVIX, is designed to prevent cervix bleeding using a suction technology to replace traumatic tenaculum (forceps).
- Xemperia — Xemperia provides diagnostic solutions that helps to detect breast cancer and early diagnosis of relapses.
- Ex Nunc Intelligence — Ex Nunc Intelligence provides professionals with thorough summaries of legal information, credible responses to legal issues, and automated legal document preparation features.
Amadeus APEX Technology Fund operates as a ventures capital firm. Amadeus APEX Technology Fund will initially invest between €1-1.5M in seed and series A stage deep tech ventures with unique and defendable technology.
Show more
Investment focus
- Chemical, CleanTech, Oil and Gas
- Seed
- Germany, Switzerland
Portfolio highlights
- UniSieve — UniSieve is a cleantech company that provides molecular separation membrane solutions for a wide range of applications. Its platform technology enables a unique combination of various molecular sieves and polymeric membranes, yielding reliable separation solutions. The company was founded in 2018 and is headquartered in Zurich, Switzerland.
- Vertus Energy — We innovate to make fossil natural gas extinct.
- ATMOS Space Cargo — ATMOS Space Cargo develops and manufactures space capsules to return cargo from space, microgravity experiments, Commercial products to entire rocket stages.
An open innovation platform of Ciech Group
Show more
Investment focus
- Chemical, CleanTech, Recycling
- Seed
- Switzerland, Poland
Portfolio highlights
- DePoly — DePoly is a spin off out of the LSMO lab at EPFL- Valais that has developed a novel technology allowing for the chemical recycling of PET plastic back to its main two components ethylene glycol (EG) and terephthalic acid (TPA). Our approach turns low valued materials (PET waste) into high-valued chemicals like TPA creating a circular economy. Weexpect this process to generate revenue from chemically recycling PET to TPA/EG, which can be sold back to industry to make new virgin PET plastic and allowing for a sustainable source of TPA and EG on the market.
- UniSieve — UniSieve is a cleantech company that provides molecular separation membrane solutions for a wide range of applications. Its platform technology enables a unique combination of various molecular sieves and polymeric membranes, yielding reliable separation solutions. The company was founded in 2018 and is headquartered in Zurich, Switzerland.
- Maxterial — Maxterial modifies the surface shape or texture of versatile materials, through a method that is very affordable and easy to introduce into the existing manufacturing process. The resulting microtextured materials dramatically reduce the contact area for the objects and droplets that contact the material surface.
Swiss ICT Investor Club (SICTIC) connects smart money investors to Swiss seed and early-stage tech startups.
Show more
Investment focus
- Software, Artificial Intelligence, Information Technology
- Seed, Pre-Seed, Funding Round
- Switzerland, Germany, United Kingdom
Portfolio highlights
- Pelt8 — Pelt8 enables climate action through the platform with scalable processes and controls to collect sustainability-related data in an easy and traceable way.
- Creaitor — Creaitor is the ultimate solution for content producers, offering a comprehensive suite of AI tools and integrated SEO features. Streamline your content creation process and optimize your online presence with our powerful platform.
- Health Yourself — Health Yourself is making routine healthcare services available digitally and from home. So far, we are offering lab tests from home, medication subscriptions and personalised supplements for health concerns ranging from sexual health to prevention.
Zürcher Kantonalbank - as an independent, incorporated public-law institution - is wholly owned by the canton of Zurich.
Show more
Investment focus
- Health Care, Medical Device, Biotechnology
- Seed, Series A, Funding Round
- Switzerland, Japan, Spain
Portfolio highlights
- Somagenetix — Somagenetix is a new firm that wants to be a leader in gene therapy by developing first-in-class treatments for phagocyte-related illnesses. Somagenetix's mission is to use genetically modified phagocytes to treat patients suffering from immunodeficiency, neurodegeneration, and cancer with brain metastases.
- Retinai — RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to collect, analyze and organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning. RetinAI has proprietarytechnology that provides unforeseen image quality enhancement, as well as automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies and device manufacturers at similar level of performance as a human would produce.
- Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
Investors by industry
Consumer
Hardware
Climate
Proptech
Gaming
Google
Marketplace
Biotech
Impact
Community
Energy
FinTech
Artificial intelligence
Health Care
EdTech
Sustainability
Venture Capital
Real Estate
Retail
Clean Energy
Food and Beverage
B2B
Video Games
Web3
Photography
Education
Big Data
Finance
Financial Services
Payments
Beauty
Publishing
Infrastructure
Organic Food
Social Network
Social Media
Digital Media
Art
Medical
Android
Franchise
Mobile
Local
Music
Legal
Enterprise Software
eSports
Construction
Sports
Internet
Wellness
Email
Manufacturing
Recruiting
Mobile Advertising
Travel
Hospitality
Cannabis
Fitness
Biotechnology
Platforms
Wine And Spirits
Automotive
Social
Medical Device
Crowdfunding
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Film
Theatre
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
Germany
United Kingdom
Canada
United States
New Zealand
South Korea
Ireland
India
Australia
Africa
Sri Lanka
Europe
Middle East
China
Qatar
Vietnam
Armenia
Oceania
Brazil
Indonesia
Asia
South Africa
Spain
Saudi Arabia
Estonia
Bermuda
Gibraltar
Belarus
Croatia
Ethiopia
Belize
Egypt
Georgia
France
Japan
Denmark
Costa Rica
Greece
Czech Republic
Singapore
Hungary
Ecuador
Faroe Islands
Chile
Ghana
LATAM
Finland
Bahrain
Algeria
Hong Kong
Belgium
Bulgaria
Liechtenstein
Barbados
Senegal
Uruguay
Puerto Rico
Sweden
El Salvador
Sierra Leone
Uganda
Slovenia
Mauritius
Taiwan
Togo
Seychelles
Zambia
Venezuela
Tajikistan
Zimbabwe
Russian Federation
Turkey
Tunisia
Uzbekistan
Thailand
Lithuania
Rwanda
San Marino
Serbia
Tanzania
Ukraine
Portugal
Poland
Dominican Republic
Italy
Bahamas
Iceland
Namibia
Nigeria
Azerbaijan
Philippines
Iraq
United Arab Emirates
Jamaica
Honduras
Mali
Liberia
Isle of Man
Bolivia
Jersey
Luxembourg
Malaysia
Albania
Pakistan
Israel
Malta
Lebanon
Norway
Jordan
Bangladesh
Myanmar
Argentina
Romania
Grenada
Morocco
Peru
Nicaragua
Mexico
Panama
Kuwait
Kazakhstan
Kenya
Cambodia
Cayman Islands
Cameroon
Cyprus
Latvia
Oman
Austria
Switzerland
Colombia
Guatemala
Marshall Islands
Investors in Switzerland by industry
Crowdfunding
Venture Capital
Film
Transportation
eSports
Cryptocurrency
Finance
Food and Beverage
Medical
Wellness
Fitness
Medical Device
Email
Hardware
Internet
Social Media
Social Network
Digital Media
Manufacturing
Music
Android
Mobile
Blockchain
Construction
Software
Legal
Enterprise Software
Sports
Automotive
Hospitality
Travel
InsurTech
Biotechnology
Recruiting
Mobile Advertising
Platforms
FinTech
Enterprise
Consumer
Health Care
EdTech
Climate
Energy
Sustainability
Proptech
SaaS
Marketplace
Artificial intelligence
Community
Gaming
Mobile Apps
Fashion
Web3
B2B
Life Science
Sporting Goods
Publishing
Education
Clean Energy
Renewable Energy
Financial Services
Real Estate
Beauty
Payments
Oil and Gas
CleanTech
Organic Food
Impact
Social Impact
Social
Restaurants
Infrastructure
Non Profit
Agriculture (agtech)
Media (entertainment)
Biotech
Video Games
Big Data
Retail